-
It has been estimated that as many as 50% of hospitalized congestive heart failure patients are malnourished.
-
Gastric fundic gland polyps can be visually horrifying when seen on endoscopy, and they are now quite commonly present in patients taking chronic acid suppressive therapy with proton pump inhibitors.
-
Numerous published studies have strongly suggested that negative emotions such as depression and anxiety contribute to the development of symptomatic coronary artery heart disease.
-
The FDA has approved the first combination NSAID and proton pump inhibitor.
-
-
Oral rofecoxib (Vioxx) may have a role in controlling postoperative pain patients undergoing knee surgery.
-
A topical estradiol emulsion has been approved for treating symptoms of menopause. Currently available estrogen products include pills, patches, and vaginal rings. The new estrogen emulsion provides another option for estrogen therapy. Novavax Inc markets this topical formulation as Estrasorb.
-
The rhythm strip shown in the Figure was obtained from a middle-aged man in severe pain from a musculoskeletal disorder. He was not having chest pain, and had no known history of cardiovascular disease. He had an episode of vomiting shortly before this tracing was recorded. Is there evidence of heart block? If so, what type?
-
Previous research failed to show that the angiotensin II antagonist losartan at 50 mg per day was as effective as captopril in reducing mortality in patients with heart failure after myocardial infarction. This raised the question of whether this new class of drugs may be substituted for ACE inhibitors in treating these high-risk patients.
-
The daily practice of emergency medicine involves life and death decisions. While training in emergency medicine focuses on life-saving procedures and medications, dying patients often seek care in the ED for symptom relief, psychosocial support, or a variety of other reasons. Education, experience, communication, and compassion can improve the emergency physicians ability to deliver medical care near the end of life that will serve to relieve suffering, improve communication of the patients preferences and goals of medical treatment, and improve overall care of the patient and family.